𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Opinion: Amyloid-β immunotherapy for Alzheimer's disease: the end of the beginning

✍ Scribed by Schenk, Dale

Book ID
109964379
Publisher
Nature Publishing Group
Year
2002
Tongue
English
Weight
461 KB
Volume
3
Category
Article
ISSN
1471-0048

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Microglial interaction with β-amyloid: I
Microglial interaction with β-amyloid: Implications for the pathogenesis of Alzheimer's disease
✍ Maria E. Bamberger; Gary E. Landreth 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB

## Abstract The etiology of Alzheimer's disease (AD) involves a significant inflammatory component as evidenced by the presence of elevated levels of a diverse range of proinflammatory molecules in the AD brain. These inflammatory molecules are produced principally by activated microglia, which are

The end of Alzheimer's disease?
The end of Alzheimer's disease?
✍ John C. S. Breitner 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 2 views

The title of this work reveals my conviction that at least a partial solution to the tragedy of Alzheimer's disease (AD) is likely in the next 20 years. The double meaning of the title is meant to introduce two themes. First, there is a ®nite risk period for AD, which has its end in extreme old age.

The amyloid-β peptide and its role in Al
The amyloid-β peptide and its role in Alzheimer's disease
✍ Andrew B. Clippingdale; John D. Wade; Colin J. Barrow 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 334 KB

## Abstract Amyloid formation plays a central role in the cause and progression of Alzheimer's disease. The major component of this amyloid is the amyloid‐β (Aβ) peptide, which is currently the subject of intense study. This review discusses some recent studies in the area of Aβ synthesis, purifica

Peripheral reduction of β-amyloid is suf
Peripheral reduction of β-amyloid is sufficient to reduce brain β-amyloid: Implications for Alzheimer's disease
✍ J. Gregor Sutcliffe; Peter B. Hedlund; Elizabeth A. Thomas; Floyd E. Bloom; Bria 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB

Three loci that modify β-amyloid (Aβ) accumulation and deposition in the brains of a mouse model of Alzheimer's disease have been previously described. One encompasses the Psen2 gene encoding presenilin 2, a component of the γ-secretase activity responsible for generating Aβ by proteolysis. We show